- Display 15 Products per page
The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery
Published: November 1, 2003 | Price: $1,875.00 – $3,750.00
The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. The pressure is on: get better lead compounds faster and at less cost. The amount of money wasted on leads that fail is excessive. And the attrition rate to get a lead is huge....
Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease
Published: October 1, 2003 | Price: $1,496.00 – $2,992.00
Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....
Growth Factors: Indications, Products, and Markets
Published: October 1, 2003 | Price: $2,625.00 – $5,250.00
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these substances have made them of great interest in various therapeutic areas for which efficacy and specificity must go hand in hand. This report analyzes the world markets for growth factors,...
Wound Care Markets Series
Published: September 1, 2003 | Price: $6,000.00 – $12,000.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. Kalorama has undertaken a major study to examine each of the three main market segments, in turn: Volume I:...
Wound Care Markets Volume III: Surgical and Trauma Wounds
Published: September 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for surgical and trauma...
OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition
Published: August 1, 2003 | Price: $1,496.00 – $2,992.00
The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others. In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to...
Men’s Health: The World Market for Current and Emerging Drug Therapies
Published: August 1, 2003 | Price: $2,625.00 – $5,250.00
This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include: · Men’s Cancer · Sexual Function · Sexually Transmitted Diseases · Urinary Conditions · Andropause The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product...
Wound Care Markets Volume II: Burns
Published: August 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for wound care for...
Advanced Drug Delivery: Technologies, Applications, and Markets
Published: July 18, 2003 | Price: $2,625.00 – $5,250.00
Drug delivery technologies continue to be a vital piece of the pharmaceutical marketing puzzle. From clinical efficacy to product differentiation and life-cycle management, delivery technologies are increasingly demanding the attention of developers at earlier and earlier stages. In Kalorama’s 2001-2002 Drug Delivery series, we focused on the markets by route of administration—oral, injectable, implantable, pulmonary, transdermal etc. In this all new study on advanced drug delivery, however, we focused on drug delivery through the lens of therapeutic application. This report...
Worldwide Market for Orthopedic Biomaterials, The
Published: July 1, 2003 | Price: $2,625.00 – $5,250.00
In today's world of Orthopedic Biomaterials, one thing that is expanding rapidly is the amount of new products in the research pipeline: stem cells, bone growth factors, gene therapy, synthetic bone fillers, bioactive implant coatings and biopolymers among others. The overall market is expected to enjoy healthy growth over the next 5 years, but the number one expansion story is in the bone growth factors and proteins segment, so called orthobiologics. These products could grow from just a few percent...
Successful Commercialization Strategies for New Healthcare Products and Technologies
Published: June 1, 2003 | Price: $995.00 – $2,992.00
According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting cancer and other diseases earlier when they are more treatable are moving from dream to reality. It is obvious that even if all of these drugs and devices make it to...
Wound Care Markets: Volume I: Skin Ulcers
Published: June 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for wound care for...
Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications
Published: May 1, 2003 | Price: $2,625.00 – $5,250.00
Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic testing services or commercial products for a genetic test in medical, GMO food safety, forensics, and paternity applications. In the area of medical genetics, tests and services can vary by disease. Under...
Market for Rx-to-OTC Switches, 3rd Edition, The
Published: May 1, 2003 | Price: $2,625.00 – $5,250.00
Switching dosages and ingredients of prescription medicines to the over-the-counter market is not new. In the past 30 years, more than 70 switches have produced hundreds of brands competing in the consumer market, and the pace promises to accelerate. Going OTC is one of a number of strategies marketers can use to extend the revenue life of their products. Appropriately coordinating the switch with patent expiry, creating coherent branding strategies, and knowing the clinical consumer climate are all factors in...
Outsourcing in Drug Discovery
Published: May 1, 2003 | Price: $2,062.00 – $4,152.00
The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely on outsourcing revenues to pay their bills and boost their credibility. Outsourcing in drug discovery is a popular topic for trade articles and seminars. These...